Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

metlife inc. - MET

MET

Close Chg Chg %
81.37 -0.47 -0.58%

Closed Market

80.90

-0.47 (0.58%)

Volume: 2.14M

Last Updated:

Dec 23, 2025, 3:59 PM EDT

Trade Now

Company Overview: metlife inc. - MET

MET Key Data

Open

$81.50

 Day Range

80.87 - 81.61

52 Week Range

65.21 - 88.08

 Market Cap

$53.75B

Shares Outstanding

658.89M

 Public Float

548.94M

Beta

0.76

 Rev. Per Employee

N/A

P/E Ratio

15.32

 EPS

$5.36

Yield

276.28%

 Dividend

$0.57

EX-DIVIDEND DATE

Nov 4, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

3.62M

  

MET Performance

1 Week
 
 -0.27%
 
1 Month
 
 8.37%
 
3 Months
 
 -0.33%
 
1 Year
 
 -1.09%
 
5 Years
 
 75.66%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 94.786
Number of Ratings 20 Current Quarters Estimate 2.356
FY Report Date 12 / 2025 Current Year's Estimate 8.694
Last Quarter’s Earnings 2.34 Median PE on CY Estimate N/A
Year Ago Earnings 8.15 Next Fiscal Year Estimate 10.00
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 14 16 16
Mean Estimate 2.36 2.24 8.69 10.00
High Estimates 2.47 2.38 8.80 10.20
Low Estimate 2.24 2.09 8.50 9.45
Coefficient of Variance 2.80 3.86 0.90 2.04

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 11 12
OVERWEIGHT 2 2 2
HOLD 7 7 6
UNDERWEIGHT 0 0 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Dec 12, 2025 Jeh Charles Johnson Director 7,425 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $77.82 per share 577,813.50
Dec 12, 2025 Diana L. McKenzie Director 22,923 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $77.82 per share 1,783,867.86
Dec 12, 2025 William E. Kennard Director 44,776 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $77.82 per share 3,484,468.32
Dec 12, 2025 Robert Glenn Hubbard Director 102,754 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $77.82 per share 7,996,316.28
Dec 12, 2025 Laura J. Hay Director 4,292 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $77.82 per share 334,003.44
Dec 12, 2025 Christian Mumenthaler Director 1,469 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $77.82 per share 114,317.58
Dec 12, 2025 Carla A. Harris Director 9,082 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $77.82 per share 706,761.24
Apr 4, 2025 Cheryl W. Grisé Director 88,189 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 7,157,419.24
Apr 4, 2025 Mark Alan Weinberger Director 16,345 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 David Lawrence Herzog Director 26,138 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 2,121,360.08
Apr 4, 2025 Edward Joseph Kelly Director 36,849 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 2,990,664.84
Apr 4, 2025 Carlos Miguel Gutierrez Director 23,289 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Denise M. Morrison Director 32,255 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Michel A. Khalaf President & CEO; Director 612,483 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 52,489,793.10
Mar 6, 2025 John D. McCallion EVP & Chief Financial Officer 245,129 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 21,007,555.30
Mar 6, 2025 Monica Melchionni Curtis EVP & Chief Legal Officer 14,872 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 1,274,530.40
Mar 6, 2025 William Pappas EVP, Global Tech. & Ops. 85,746 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 7,348,432.20
Mar 6, 2025 Marlene B. Debel EVP & Chief Risk Officer 134,135 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 11,495,369.50
Mar 6, 2025 Ramy Tadros President, U.S. Business 181,368 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 15,543,237.60
Mar 6, 2025 Tamara L. Schock EVP & Chief Accounting Officer 23,606 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 2,023,034.20

Metlife Inc. in the News